ZEISS Attends the CIIE for the Third Consecutive Time to Showcase Innovative Optical Technologies

SHANGHAI,Nov.7,2020 -- The opening ceremony of the third China International Import Expo (CIIE) took placeat the National Convention and Exhibition Center (Shanghai) on November 4,demonstrating China's open and inclusive attitude to the world. This is the third consecutive time for ZEISSto attend the CIIE.The company is againshowcasing its innovativetechnologiesmeeting the needs inthe China market and the trends of the industry.

Maximilian Foerst,President and Managing Director of ZEISS Greater China,said: "It's the third time for us to attend the CIIE. Thanks to the powerful'spillover effects'of the event over the previous twoyears,ZEISShas achieved growthin medtech,NEVs,high-end scientific research,and eye health. In the next five years,ZEISS will continue focusingonChinaas strategic business and innovation center,collaborating with partnersfor a betterfuture."

Leveraging optical expertise to help China combat COVID-19

This year,COVID-19 has caused a huge impact on global economy. China quicklyrecovered fromthe pandemic. Thanks to China's outstanding performancein epidemic control,ZEISSChina's business beganto grow again inMarch 2020.

During the pandemic,ZEISS stepped up the development of preventive and protective supplies on the basis of itshigh technology. For example,ZEISS Germany designed a protective screen for ophthalmologists and patients,which was optimized and quickly manufacturedin China,and was delivered to customers around the world. This is a demonstration of the company's"In China,for global"strategy. At the third CIIE,ZEISSannounced the its first antiviruslensesthatcan actively fight and kill viruses and bacteria at the CIIE.This is the first time thatviral inactivation is used on optical lenses forconsumers. The innovationattracted extensive attention from Chinese and overseas customers.

Meanwhile,ZEISSalsodonated itslens wipes,protective goggles,clear lens glasses,slit lamp breath shieldsand various other personal protective equipment (PPE)to people fighting COVID-19 on the frontlinesacross China when the pandemic ran rampant,to help protect themselves.

Taking advantage of the CIIE to promote global trade recovery

Today,China has become the largest and one of the most important markets for ZEISS in the world. The CIIE is the world's onlymajorinternational expoconfirmed to be held in the second half of this year.Attending the CIIE for three consecutive years demonstratedZEISS' long-term commitment to the Chinamarket. This year,ZEISS put a higher premium onthegreatopportunity ofthe CIIE. It brought variousoptical products that had played an important role in China's epidemic controlto the CIIE,to share them with its peers. Meanwhile,when it comes to public healthwhere ZEISS has a long-term interest,it has signed the Letter of Intent forcooperation with several industry partnersincludingthe National Clinical Research Centerfor Eye Disease and Tencent Healthcare,aiming to promote eye healthin Chinaandboost global traderecovery together.

The successful opening of the third CIIE underscored China's confidence in its economic growth,and also cemented ZEISS' determination to further invest and expand in China. In the future,ZEISS will continue to take the Chinamarket as itsstrategic focusin the world,bring more cutting-edgeandinnovative optical technologies and productsmeeting the needs of Chinese customers,and work with various partnersonwin-wintermsto help create more miracles for economic and social developmentin China.

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the 2019/20 fiscal year,the ZEISS Group generated annual revenue totaling more than 6.2 billion euros in its four segments Semiconductor Manufacturing Technology,Industrial Quality & Research,Medical Technology and Consumer Markets (status: 30 September 2020).

For its customers,ZEISS develops,produces and distributes highly innovative solutions for industrial metrology and quality assurance,microscopy solutions for the life sciences and materials research,and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics,which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses,camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization,healthcare and Smart Production and a strong brand,ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant,sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.

With over 32,000 employees,ZEISS is active globally in almost 50 countries with around 60 sales and service companies,30 production sites and 25 development sites. Founded in 1846 in Jena,the company is headquartered in Oberkochen,Germany. The Carl Zeiss Foundation,one of the largest foundations in Germany committed to the promotion of science,is the sole owner of the holding company,Carl Zeiss AG.

Further Information: www.zeiss.com